The US Food and Drug Administration has issued new draft guidance to help manufacturers develop and seek approval for artificial pancreas device systems for type 1 diabetes. To date, no such device has been approved for marketing in the US. ---Subscribe to MedNous to access this article--- Regulation & Policy
